Table III.
PvuII and XbaI haplotypes (%) | Subject no. | Country/region | Author group (Refs) | |||
---|---|---|---|---|---|---|
PX | Px | pX | px | |||
20.5 | 24.8 | 24.8 | 29.9 | 234 | Taiwan | This study |
18.7 | 26.5 | 0.3 | 54.5 | 238 | Japan | Kobayashi et al (44) |
18.3 | 22.3 | 0 | 59.4 | 2226 | Japan | Yamada et al (45) |
9.5 | 20.6 | 22.0 | 47.9 | 73 | Japan | Niino et al (46) |
7.9 | 35.9 | 10.2 | 46.0 | 551 | Japan | Kazama et al (47) |
6.8 | 28.4 | 12.4 | 52.4 | 125 | China | Lin et al (48) |
18.5 | 22.3 | 2.3 | 57.7 | 598 | Korea | Han et al (49) |
8.6 | 30.4 | 13.4 | 47.6 | 219 | Korea | Koh et al (50) |
6.2 | 30.7 | 10.6 | 52.5 | 268 | Korea | Lee et al (51) |
33.7 | 13.3 | 0 | 53.0 | 454 | Denmark | Bagger et al (52) |
36.1 | 10.9 | 0 | 53.0 | 1100 | Netherlands | Van Meurs et al (53) |
50.0 | 13.6 | 0 | 36.8 | 19 | United States (African) | Van Meurs et al (53) |
33.5 | 9.2 | 1.2 | 56.1 | 206 | United Kingdom | Albagha et al (54) |
40.9 | 5.7 | 1.3 | 52.1 | 610 | Italy | Becherini et al (55) |
35.6 | 9.5 | 0 | 54.9 | 662 | Canada | Patel et al (56) |
17.3 | 24.4 | 10.9 | 47.4 | 64 | Poland | Jakimiuk et al (57) |